NYSEARCA:LABD Direxion Daily S&P Biotech Bear 3x Shares (LABD) Price, Holdings, & News $6.58 -0.21 (-3.14%) As of 11:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipShort InterestBuy This Stock About Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LABD alerts:Sign Up Key Stats Today's Range$6.48▼$6.7550-Day Range$6.09▼$7.7352-Week Range$4.78▼$16.05Volume6.06 million shsAverage Volume14.70 million shsMarket Capitalization$105.36 millionAssets Under Management$57.89 millionDividend Yield4.11%Net Expense Ratio1.07%Aggregate RatingN/A ETF Overview The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion. Read More Direxion Daily S&P Biotech Bear 3x Shares ExpensesTypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.56%0.56%0.51%0.53%Other Expenses0.33%0.47%0.56%0.59%0.56%Total Expense1.08%0.75%0.76%0.74%0.73%Fee Waiver-0.01%-0.67%-0.66%-0.71%-0.63%Net Expense1.07%0.60%0.63%0.58%0.60% Receive LABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address LABD ETF News HeadlinesDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0370June 24, 2025 | msn.comTSLL, LABD: Big ETF OutflowsMay 13, 2025 | nasdaq.comAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.August 12 at 2:00 AM | Paradigm Press (Ad)Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.1264December 24, 2024 | msn.comDirexion Daily S&P Biotech Bear 3X Shares (LABD) Dividend HistoryDecember 23, 2024 | nasdaq.comDirexion Daily S&P 500 Bear 3X (ARCA:SPXS), Short Interest ReportOctober 14, 2024 | benzinga.comSee More Headlines LABD ETF - Frequently Asked Questions How have LABD shares performed this year? Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $7.25 at the start of the year. Since then, LABD shares have decreased by 9.1% and is now trading at $6.5930. When did Direxion Daily S&P Biotech Bear 3x Shares' stock split? Direxion Daily S&P Biotech Bear 3x Shares's stock reverse split on Friday, August 28th 2020.The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bear 3x Shares' major shareholders? Direxion Daily S&P Biotech Bear 3x Shares' top institutional investors include Envestnet Asset Management Inc. (0.09%). How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares? Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3x Shares investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), Direxion Daily S&P Biotech Bull 3x Shares (LABU), NVIDIA (NVDA) and Intel (INTC). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bear 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABD Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings24 Fund Statistics Assets Under Management$57.89 million Average Daily Volume$17.89 million Discount/Premium-0.01% Leveraged-3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume3,469 Put Options204 Call Options3,265 Short Interest1,610,000 shs Miscellaneous Outstanding Shares16,020,000Beta-2.40 Creation Unit50,000 Creation Fee$250.00 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report Top 10 LABD HoldingsDreyfus Govt Cash Man InsHolding Weight: 49.91%Goldman Sachs Sterling FixInc Port IncHolding Weight: 42.00%Goldman Sachs Fin Gov 465 InstitutHolding Weight: 20.41%Dreyfus Trsry Securities Cash MgmtHolding Weight: 12.28%CashHolding Weight: 0.02%Jpm CollateralHolding Weight: -1.59%Baml CollateralHolding Weight: -3.13%Citi CollateralHolding Weight: -4.79%Goldman CollateralHolding Weight: -6.48%S&P Biotechnology Select Industry Index SwapHolding Weight: -8.62%Full Holdings Details This page (NYSEARCA:LABD) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bear 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.